General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Cash Flows

v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jul. 31, 2020
Feb. 28, 2023
Nov. 30, 2022
Aug. 31, 2022
Feb. 28, 2022
[1]
Nov. 30, 2021
[1]
Aug. 31, 2021
[1]
Feb. 28, 2021
Nov. 30, 2020
Nov. 30, 2021
Nov. 30, 2020
Feb. 28, 2023
Feb. 28, 2022
[1]
Feb. 28, 2021
May 31, 2022
May 31, 2021
May 31, 2020
Cash flows from operating activities:                                  
Net loss   $ (13,702) $ (26,495) $ (20,991) $ (41,285) [2] $ (40,077) $ (45,337) $ (37,581) $ (37,980) $ (85,414) $ (68,812) $ (61,188) $ (126,699) [2] $ (106,393) $ (210,820) $ (176,465)  
Adjustments to reconcile net loss to net cash used in operating activities:                                  
Amortization and depreciation   12     129             165 657   781 1,797  
Amortization of debt issuance costs   17     19             51 70   87 65  
Amortization of discount on convertible notes   565     637             1,721 2,382   2,958 3,591  
Warrants issued for legal settlement                         1,744   3,663    
Loss on derivatives                       8,756          
Finance charges related to warrant issuance for surety bond backstop agreement                             6,585    
Loss on induced conversion   2,018 $ 638   12,066 $ 6,785 18,530         2,656 37,381   37,381 39,131  
Inducement interest expense and non-cash finance charges                       4,885 14,270   6,691 13,922  
Inventory charge       2,700 5,559             20,633 8,916   73,490 5,027  
Stock-based compensation $ 1,600                     3,557 4,219   6,239 10,429  
Intangible asset impairment charge               $ 10,000             0 10,049 $ 0
Changes in operating assets and liabilities:                                  
Decrease (increase) in inventories                             2,060 (79,359)  
(Increase) decrease in prepaid expenses and other assets                       624 (3,264)   (4,125) 1,228  
Decrease in accounts payable and accrued expenses                       (3,558) (11,355)   (2,713) 53,012  
Net cash used in operating activities                       (21,698) (71,679)   (77,723) (117,573)  
Cash flows from investing activities:                                  
Furniture and equipment purchases                         (30)     (122)  
Net cash used in investing activities                         (30)     (122)  
Cash flows from financing activities:                                  
Proceeds from warrant transactions, net of offering costs                       2,815 5,390   5,390 17,060  
Proceeds from sale of common stock and warrants, net of issuance costs                       24,601 33,313   41,195 1,000  
Proceeds from warrant exercises                       264 1,036   1,036 19,428  
Payment on convertible notes                               (950)  
Release of restricted cash held in trust for warrant tender offer                               (10)  
Proceeds held in escrow                       897          
Proceeds from stock option exercises                         390   390 1,839  
Payment of payroll withholdings related to tender of common stock for income tax withholding                               (778)  
Proceeds from convertible notes payable, net                               100,000  
Dividend declared and paid on Series B Preferred Stock                               (243)  
Net cash provided by financing activities                       28,577 40,129   48,011 137,346  
Net change in cash and restricted cash                       6,879 (31,580)   (29,712) 19,651  
Cash at beginning of period       $ 4,231     $ 33,943     $ 33,943 [1] $ 14,292 4,231 33,943 $ 14,292 33,943 [1] 14,292  
Cash and restricted cash at end of period   11,110     2,363             11,110 2,363   4,231 33,943 [1] 14,292
Cash and restricted cash consisted of the following:                                  
Cash   5,112     1,363             5,112 1,363   4,231 33,943  
Restricted cash   5,998     1,000             5,998 1,000        
Total cash and restricted cash   11,110     $ 2,363             11,110 2,363   4,231 33,943 [1] $ 14,292
Supplemental disclosure:                                  
Cash paid for interest                         63   63 147  
Non-cash investing and financing transactions:                                  
Derivative liability associated with warrants                       8,756          
Issuance of common stock for principal and interest of convertible notes                       2,000 31,001   31,000 57,807  
Accrued dividends on Series C and D convertible preferred stock                       1,117 988   1,636 1,666  
Dividend paid in common stock on Series B and C convertible preferred stock conversions                       159 260        
Warrants Issued To Placement Agent Recorded In Additional Paid In Capital                       7,380 1,293        
Warrants Issued For Surety Bond Backstop Agreement                       4,885 $ 6,585        
Cashless exercise of warrants                             $ 1 $ 11  
Deemed dividend due to equity modifications, recorded in additional paid-in capital   $ 5,417                   $ 5,417          
[1] See Note 2, Summary of Significant Accounting PoliciesRevision and Restatement of Financial Statements.
[2] See Note 2, Summary of Significant Accounting Policies